Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Manidhar Lekkala"'
Autor:
Amirahwaty Abdullah, Manidhar Lekkala, Zachary Wolfe, Charumathi Raghu, Safi Ullah Khan, Mrinalini Krishnan, Lydia Winnicka, Bradley Lash
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 365-371 (2018)
Background: The treatment of metastatic renal cell carcinoma (RCC) has been radically changed by the advent of tyrosine kinase inhibitors (TKIs). However, few reports have described their role in cardiac metastases. We present a case of a left ventri
Externí odkaz:
https://doaj.org/article/6c4c17139574471097d8402979112d8c
Publikováno v:
JCO Oncology Practice. 18:e626-e631
PURPOSE: Delivering care for immunocompromised, high-risk patients with cancer during a pandemic has proven challenging. Patients with cancer on chemotherapy have a high risk of mortality if contracted COVID-19. If a patient goes directly to the emer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8fe213bf64afeefc31d54688e0394ee
https://doi.org/10.1200/op.21.00126
https://doi.org/10.1200/op.21.00126
Publikováno v:
Expert Review of Precision Medicine and Drug Development. 5:401-408
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of malignancies which make up approximately 5% of all cancers worldwide. Molecular profiling of HNSCC tumors has identified ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::518079d4fea813ea09969e038f6682de
https://doi.org/10.1080/23808993.2020.1799710
https://doi.org/10.1080/23808993.2020.1799710
Autor:
Bahar Moftakhar, Bryan Fitzgerald, Manidhar Lekkala, Myla Strawderman, Philip J. Meacham, Tae C Smith, Ajay Dhakal
Publikováno v:
Cancer Research. 80:P1-19
Background: Palbociclib (palbo), a CDK4/6 inhibitor, is commonly added to an aromatase inhibitor (AI) as the first line therapy in managing estrogen receptor positive, HER2 non amplified (ER+ HER2-) metastatic breast cancer (MBC). Though more tolerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::119aced514619af681a9c5e4bcaafb5f
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-23
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-23
Autor:
Anup Kasi, Pramod Gaudel, Manidhar Lekkala, Raed Al-Rajabi, Anwaar Saeed, Weijing Sun, Charles Porter
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311618
Introduction Fluoropyrimidines (FP) are cornerstone drugs in the treatment of gastrointestinal (GI) malignancies. Cardiotoxicity secondary to an FP chemotherapy is a serious complication. There are no standardized guidelines on the treatment of FP in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::259443d0d0c1f1a71c85345cd77ebe25
https://doi.org/10.1177/10781552231161822
https://doi.org/10.1177/10781552231161822
Autor:
Achint Patel, Manidhar Lekkala, Jessica Ohemeng-Dapaah, Arathi Rajeev, Sanjana Mullangi, Maheshkumar Desai, Praneeth Reddy Keesari, Yashwitha Sai Pulakurthi, Frank Adusei Poku, Anas Zaher, Prasanna Lakshmi Vidiyala, Yaw Asare, Asha Latha Guntupalli
Publikováno v:
Cureus
Background Hepatocellular Carcinoma (HCC) is a severe complication of cirrhosis and the incidence of HCC has been increasing in the United States (US). We aim to describe the trends, characteristics, and outcomes of hospitalizations due to HCC across
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23712ef9ece266606f53719359a82920
https://pubmed.ncbi.nlm.nih.gov/35003948
https://pubmed.ncbi.nlm.nih.gov/35003948
Autor:
Charumathi Raghu Subramanian, Manidhar Lekkala, Sanjana Mullangi, Bahar Moftakhar, Swapna Talluri
Publikováno v:
Cureus
Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0eb57ad61dcc8cabb05e1e7882136c9
https://doi.org/10.7759/cureus.13332
https://doi.org/10.7759/cureus.13332
Autor:
Bryan Fitzgerald, Ajay Dhakal, Myla Strawderman, Manidhar Lekkala, Carla I. Falkson, Tae C Smith, Philip J. Meacham, Bahar Moftakhar
Publikováno v:
Breast cancer research and treatment. 183(2)
Palbociclib is commonly added to an aromatase inhibitor (AI) as first-line therapy in ER + HER2- metastatic breast cancer (MBC). There are no data on the effect of the relative dose intensity (RDI) of palbociclib in first-line setting on clinical out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3039a5e8872eeddb192104f33fdf241
https://pubmed.ncbi.nlm.nih.gov/32671612
https://pubmed.ncbi.nlm.nih.gov/32671612
Autor:
Sudhakar Sattur, Muhammad Khan, Haris Riaz, Safi U. Khan, Manidhar Lekkala, Edo Kaluski, Hammad Rahman, Harshil Shah, Swapna Talluri
Publikováno v:
Eur J Prev Cardiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552606c1f6338612c90095f91bcf2b0a
https://doi.org/10.1177/2047487318788613
https://doi.org/10.1177/2047487318788613
Autor:
Safi U. Khan, Mrinalini Krishnan, Manidhar Lekkala, Charumathi Raghu, Lydia Winnicka, Amirahwaty Abdullah, Zachary Wolfe, Bradley Lash
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 11, Iss 2, Pp 365-371 (2018)
Case Reports in Oncology, Vol 11, Iss 2, Pp 365-371 (2018)
Background: The treatment of metastatic renal cell carcinoma (RCC) has been radically changed by the advent of tyrosine kinase inhibitors (TKIs). However, few reports have described their role in cardiac metastases. We present a case of a left ventri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab21bd49d6caf379ec89740a7f29266
http://europepmc.org/articles/PMC6031946
http://europepmc.org/articles/PMC6031946